carnitine has been researched along with Metabolic Syndrome in 33 studies
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intravenous L-carnitine can ameliorate fasting-induced hunger, fatigue, cholesterol abnormalities and hepatic metabolic changes and facilitate fasting-induced weight loss in MetS patients." | 9.19 | L-carnitine ameliorated fasting-induced fatigue, hunger, and metabolic abnormalities in patients with metabolic syndrome: a randomized controlled study. ( Cai, YJ; Huang, YJ; Ke, B; Qin, J; Qiu, CP; Shi, LY; Wu, ZB; Yang, YB; Zhang, JJ, 2014) |
| "A systematic review and meta-analysis of randomized controlled trials (RCTs) was carried out to assess L-carnitine supplements' influence on the biomarkers of metabolic syndrome (MetSyn)." | 9.05 | L-Carnitine's Effect on the Biomarkers of Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. ( Choi, M; Lee, M; Park, S, 2020) |
| "We sought to compare serum carnitine levels and clinical correlates between stable outpatients and acutely hospitalised individuals with diagnoses of bipolar disorder and schizophrenia." | 7.83 | Comparison of serum carnitine levels and clinical correlates between outpatients and acutely hospitalised individuals with bipolar disorder and schizophrenia: A cross-sectional study. ( Abramson, RK; Breen, RJ; Cuturic, M; Edwards, AC; Levy, EE, 2016) |
| "In type 1 diabetes (T1D), type 2 diabetes (T2D) and metabolic syndrome (MetS), the associated complex metabolomic changes in the involvement of carnitine metabolism in total carnitine ester level has already been documented; here we extended the investigations to the individual acylcarnitines." | 7.79 | Similarities in serum acylcarnitine patterns in type 1 and type 2 diabetes mellitus and in metabolic syndrome. ( Bagosi, Z; Bene, J; Bujtor, Z; Gasztonyi, B; Márton, M; Melegh, B; Mohás, M; Oroszlán, T; Wittmann, I, 2013) |
| " The effects of the Zn(ii) complex with ascorbic acid (Vitamin C; VC), methylmethionine sulfonium chloride (Vitamin U; VU) and l-carnitine were assessed in diet-induced metabolic syndrome model rats." | 7.77 | Effects of Zn(II) complex with vitamins C and U, and carnitine on metabolic syndrome model rats. ( Fujii, T; Kajiwara, N; Matsumoto, K; Motoyasu, N; Sera, K; Taniguchi, H; Yasui, H; Yoshikawa, Y, 2011) |
| "Eighty percent of cases had NAFLD with increase in chemerin as severity of NAFLD increased." | 5.43 | Serum Chemerin in Obese Children and Adolescents Before and After L-Carnitine Therapy: Relation to Nonalcoholic Fatty Liver Disease and Other Features of Metabolic Syndrome. ( Ebrahim, AO; Elkabbany, ZA; Hamed, AI; Hamza, RT; Shedid, AM, 2016) |
| "Rats fed high dosage of fructose that form a well-known experimental model of the metabolic syndrome also display progressive renal disturbances." | 5.35 | Renoprotective action of L-carnitine in fructose-induced metabolic syndrome. ( Anuradha, CV; Rajasekar, P; Viswanathan, P, 2008) |
| "Intravenous L-carnitine can ameliorate fasting-induced hunger, fatigue, cholesterol abnormalities and hepatic metabolic changes and facilitate fasting-induced weight loss in MetS patients." | 5.19 | L-carnitine ameliorated fasting-induced fatigue, hunger, and metabolic abnormalities in patients with metabolic syndrome: a randomized controlled study. ( Cai, YJ; Huang, YJ; Ke, B; Qin, J; Qiu, CP; Shi, LY; Wu, ZB; Yang, YB; Zhang, JJ, 2014) |
| "To determine the effects of a weight loss program, including dietary modifications, increased physical activity and dietary supplement (L-carnitine or placebo) on anthropometrics, leptin, insulin, the metabolic syndrome (MS) and insulin resistance in overweight /obese premenopausal women." | 5.11 | Weight loss favorably modifies anthropometrics and reverses the metabolic syndrome in premenopausal women. ( Brownbill, RA; Fernandez, ML; Herron, KL; Ilich, JZ; Koo, SI; Lofgren, IE; West, KL; Zern, TL, 2005) |
| "A systematic review and meta-analysis of randomized controlled trials (RCTs) was carried out to assess L-carnitine supplements' influence on the biomarkers of metabolic syndrome (MetSyn)." | 5.05 | L-Carnitine's Effect on the Biomarkers of Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. ( Choi, M; Lee, M; Park, S, 2020) |
| "We sought to compare serum carnitine levels and clinical correlates between stable outpatients and acutely hospitalised individuals with diagnoses of bipolar disorder and schizophrenia." | 3.83 | Comparison of serum carnitine levels and clinical correlates between outpatients and acutely hospitalised individuals with bipolar disorder and schizophrenia: A cross-sectional study. ( Abramson, RK; Breen, RJ; Cuturic, M; Edwards, AC; Levy, EE, 2016) |
| "In this study, we evaluated the effect of an analogue of l-carnitine on parameters involved with Metabolic Syndrome in obese Zucker rats." | 3.79 | Pharmacological evaluation of a β-hydroxyphosphonate analogue of l-carnitine in obese Zucker fa/fa rats. ( De la Cruz-Cordero, R; Duarte-Vázquez, MÁ; Mendoza-Rivera, B; Reyes-Esparza, J; Rodríguez-Fragoso, L; Rosado, JL; Solis, MG; Vite-Vallejo, O, 2013) |
| "In type 1 diabetes (T1D), type 2 diabetes (T2D) and metabolic syndrome (MetS), the associated complex metabolomic changes in the involvement of carnitine metabolism in total carnitine ester level has already been documented; here we extended the investigations to the individual acylcarnitines." | 3.79 | Similarities in serum acylcarnitine patterns in type 1 and type 2 diabetes mellitus and in metabolic syndrome. ( Bagosi, Z; Bene, J; Bujtor, Z; Gasztonyi, B; Márton, M; Melegh, B; Mohás, M; Oroszlán, T; Wittmann, I, 2013) |
| " The effects of the Zn(ii) complex with ascorbic acid (Vitamin C; VC), methylmethionine sulfonium chloride (Vitamin U; VU) and l-carnitine were assessed in diet-induced metabolic syndrome model rats." | 3.77 | Effects of Zn(II) complex with vitamins C and U, and carnitine on metabolic syndrome model rats. ( Fujii, T; Kajiwara, N; Matsumoto, K; Motoyasu, N; Sera, K; Taniguchi, H; Yasui, H; Yoshikawa, Y, 2011) |
| "Recently we showed that the administration of intraperitoneal L-carnitine (CA) has insulin-sensitizing effects in the high fructose-fed Wistar rat, a widely used model of metabolic syndrome." | 3.74 | Increase in nitric oxide and reductions in blood pressure, protein kinase C beta II and oxidative stress by L-carnitine: a study in the fructose-fed hypertensive rat. ( Anuradha, CV; Palanisamy, N; Rajasekar, P, 2007) |
| "Glycine and AC10 were specific metabolites representative of discrimination according to sex-dependent MetS." | 1.72 | Targeted Metabolomics Revealed a Sex-Dependent Signature for Metabolic Syndrome in the Mexican Population. ( Canizales-Quinteros, S; Flores, YN; Ibarra-González, I; León-Reyes, G; Palacios-González, B; Rivera-Paredez, B; Salmerón, J; Vela-Amieva, M; Velázquez-Cruz, R, 2022) |
| "Choline was not significantly altered in MetS." | 1.48 | Changes to trimethylamine-N-oxide and its precursors in nascent metabolic syndrome. ( Huet, B; Jialal, I; Lent-Schochet, D; McLaughlin, M; Silva, R, 2018) |
| "Eighty percent of cases had NAFLD with increase in chemerin as severity of NAFLD increased." | 1.43 | Serum Chemerin in Obese Children and Adolescents Before and After L-Carnitine Therapy: Relation to Nonalcoholic Fatty Liver Disease and Other Features of Metabolic Syndrome. ( Ebrahim, AO; Elkabbany, ZA; Hamed, AI; Hamza, RT; Shedid, AM, 2016) |
| "The purpose of this research was to describe the pharmacokinetic parameters of β-hydroxyphosphocarnitine (β-HPC; CAS No." | 1.40 | Pharmacokinetic and pharmacological effects of β-hydroxyphosphocarnitine in animal models. ( De la Cruz-Cordero, R; Duarte-Vázquez, MÁ; Mendoza-Rivera, B; Reyes-Esparza, J; Rodríguez-Fragoso, L; Rosado, JL, 2014) |
| "Obesity has reached epidemic proportions worldwide." | 1.38 | Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation. ( Brauer, HA; Freemerman, AJ; Galanko, JA; Ilkayeva, OR; Kuan, PF; Makowski, L; Muehlbauer, MJ; Newgard, CB; O'Connell, TM; Sampey, BP; Stevens, RD; Troester, MA; Zhang, J, 2012) |
| "Rats fed high dosage of fructose that form a well-known experimental model of the metabolic syndrome also display progressive renal disturbances." | 1.35 | Renoprotective action of L-carnitine in fructose-induced metabolic syndrome. ( Anuradha, CV; Rajasekar, P; Viswanathan, P, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (15.15) | 29.6817 |
| 2010's | 16 (48.48) | 24.3611 |
| 2020's | 12 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Palacios-González, B | 1 |
| León-Reyes, G | 1 |
| Rivera-Paredez, B | 1 |
| Ibarra-González, I | 1 |
| Vela-Amieva, M | 1 |
| Flores, YN | 1 |
| Canizales-Quinteros, S | 1 |
| Salmerón, J | 1 |
| Velázquez-Cruz, R | 1 |
| Gao, X | 1 |
| Sun, C | 1 |
| Zhang, Y | 1 |
| Hu, S | 1 |
| Li, D | 1 |
| Taghizadeh, H | 1 |
| Emamgholipour, S | 1 |
| Hosseinkhani, S | 1 |
| Arjmand, B | 1 |
| Rezaei, N | 1 |
| Dilmaghani-Marand, A | 1 |
| Ghasemi, E | 1 |
| Panahi, N | 1 |
| Dehghanbanadaki, H | 1 |
| Ghodssi-Ghassemabadi, R | 1 |
| Najjar, N | 1 |
| Asadi, M | 1 |
| Khoshniat, M | 1 |
| Larijani, B | 1 |
| Razi, F | 1 |
| Lee, YH | 1 |
| Park, S | 2 |
| Niska-Blakie, J | 1 |
| Gopinathan, L | 1 |
| Low, KN | 1 |
| Kien, YL | 1 |
| Goh, CMF | 1 |
| Caldez, MJ | 1 |
| Pfeiffenberger, E | 1 |
| Jones, OS | 1 |
| Ong, CB | 1 |
| Kurochkin, IV | 1 |
| Coppola, V | 1 |
| Tessarollo, L | 1 |
| Choi, H | 1 |
| Kanagasundaram, Y | 1 |
| Eisenhaber, F | 1 |
| Maurer-Stroh, S | 1 |
| Kaldis, P | 1 |
| Gong, LL | 1 |
| Yang, S | 1 |
| Zhang, W | 1 |
| Han, FF | 1 |
| Xuan, LL | 1 |
| Lv, YL | 1 |
| Liu, H | 1 |
| Liu, LH | 1 |
| Choi, M | 1 |
| Lee, M | 1 |
| Cao, B | 1 |
| Chen, Y | 1 |
| McIntyre, RS | 1 |
| Yan, L | 1 |
| Jialal, I | 2 |
| Patel, A | 1 |
| Devaraj, S | 1 |
| Adams-Huet, B | 1 |
| Poulos, JE | 1 |
| Kalogerinis, PT | 1 |
| Milanov, V | 1 |
| Kalogerinis, CT | 1 |
| Poulos, EJ | 1 |
| Khodorova, NV | 1 |
| Rietman, A | 1 |
| Rutledge, DN | 1 |
| Schwarz, J | 1 |
| Piedcoq, J | 1 |
| Pilard, S | 1 |
| Siebelink, E | 1 |
| Kok, FJ | 1 |
| Tomé, D | 1 |
| Mensink, M | 1 |
| Azzout-Marniche, D | 1 |
| Zhao, X | 2 |
| Feng, X | 1 |
| Jiang, Y | 1 |
| Li, X | 1 |
| Niu, J | 1 |
| Meng, X | 1 |
| Wu, J | 1 |
| Xu, G | 1 |
| Hou, L | 1 |
| Wang, Y | 1 |
| Lent-Schochet, D | 1 |
| Silva, R | 1 |
| McLaughlin, M | 1 |
| Huet, B | 1 |
| Zayed, EA | 1 |
| AinShoka, AA | 1 |
| El Shazly, KA | 1 |
| Abd El Latif, HA | 1 |
| Ma, Y | 1 |
| Sun, L | 1 |
| Li, J | 1 |
| Hu, Y | 1 |
| Gan, Z | 1 |
| Zong, G | 1 |
| Zheng, H | 1 |
| Jin, Q | 1 |
| Li, H | 1 |
| Hu, FB | 1 |
| Zeng, R | 1 |
| Sun, Q | 1 |
| Lin, X | 1 |
| Joris, BR | 1 |
| Gloor, GB | 1 |
| Johri, AM | 1 |
| Heyland, DK | 1 |
| Hétu, MF | 1 |
| Crawford, B | 1 |
| Spence, JD | 1 |
| Reyes-Esparza, J | 2 |
| Mendoza-Rivera, B | 2 |
| De la Cruz-Cordero, R | 2 |
| Duarte-Vázquez, MÁ | 2 |
| Rosado, JL | 2 |
| Rodríguez-Fragoso, L | 2 |
| Zhang, JJ | 1 |
| Wu, ZB | 1 |
| Cai, YJ | 1 |
| Ke, B | 1 |
| Huang, YJ | 1 |
| Qiu, CP | 1 |
| Yang, YB | 1 |
| Shi, LY | 1 |
| Qin, J | 1 |
| Virmani, A | 1 |
| Pinto, L | 1 |
| Bauermann, O | 1 |
| Zerelli, S | 1 |
| Diedenhofen, A | 1 |
| Binienda, ZK | 1 |
| Ali, SF | 1 |
| van der Leij, FR | 1 |
| Panchal, SK | 1 |
| Poudyal, H | 1 |
| Ward, LC | 1 |
| Waanders, J | 1 |
| Brown, L | 1 |
| Cuturic, M | 1 |
| Abramson, RK | 1 |
| Breen, RJ | 1 |
| Edwards, AC | 1 |
| Levy, EE | 1 |
| Allam-Ndoul, B | 1 |
| Guénard, F | 1 |
| Garneau, V | 1 |
| Cormier, H | 1 |
| Barbier, O | 1 |
| Pérusse, L | 1 |
| Vohl, MC | 1 |
| Hamza, RT | 1 |
| Elkabbany, ZA | 1 |
| Shedid, AM | 1 |
| Hamed, AI | 1 |
| Ebrahim, AO | 1 |
| Mingorance, C | 1 |
| Gonzalez del Pozo, M | 1 |
| Dolores Herrera, M | 1 |
| Alvarez de Sotomayor, M | 1 |
| Matsumoto, K | 1 |
| Motoyasu, N | 1 |
| Sera, K | 1 |
| Fujii, T | 1 |
| Yoshikawa, Y | 1 |
| Yasui, H | 1 |
| Taniguchi, H | 1 |
| Kajiwara, N | 1 |
| Sampey, BP | 1 |
| Freemerman, AJ | 1 |
| Zhang, J | 1 |
| Kuan, PF | 1 |
| Galanko, JA | 1 |
| O'Connell, TM | 1 |
| Ilkayeva, OR | 1 |
| Muehlbauer, MJ | 1 |
| Stevens, RD | 1 |
| Newgard, CB | 1 |
| Brauer, HA | 1 |
| Troester, MA | 1 |
| Makowski, L | 1 |
| Solis, MG | 1 |
| Vite-Vallejo, O | 1 |
| Bene, J | 1 |
| Márton, M | 1 |
| Mohás, M | 1 |
| Bagosi, Z | 1 |
| Bujtor, Z | 1 |
| Oroszlán, T | 1 |
| Gasztonyi, B | 1 |
| Wittmann, I | 1 |
| Melegh, B | 1 |
| Lofgren, IE | 1 |
| Herron, KL | 1 |
| West, KL | 1 |
| Zern, TL | 1 |
| Brownbill, RA | 1 |
| Ilich, JZ | 1 |
| Koo, SI | 1 |
| Fernandez, ML | 1 |
| Rajasekar, P | 3 |
| Viswanathan, P | 2 |
| Anuradha, CV | 3 |
| Palanisamy, N | 1 |
3 reviews available for carnitine and Metabolic Syndrome
| Article | Year |
|---|---|
L-Carnitine's Effect on the Biomarkers of Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Topics: Aged; Biomarkers; Blood Glucose; Blood Pressure; Cardiometabolic Risk Factors; Carnitine; Cholestero | 2020 |
Unaccounted risk of cardiovascular disease: the role of the microbiome in lipid metabolism.
Topics: Animals; Atherosclerosis; Bile Acids and Salts; Carnitine; Choline; Energy Metabolism; Fatty Acids, | 2019 |
Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: evidence and controversies.
Topics: Administration, Oral; Animals; Athletes; Blood Pressure; Cardiovascular Diseases; Carnitine; Cholest | 2014 |
3 trials available for carnitine and Metabolic Syndrome
| Article | Year |
|---|---|
Urinary Medium-Chained Acyl-Carnitines Sign High Caloric Intake whereas Short-Chained Acyl-Carnitines Sign High -Protein Diet within a High-Fat, Hypercaloric Diet in a Randomized Crossover Design Dietary Trial.
Topics: Adult; Biomarkers; Carnitine; Cross-Over Studies; Diet, High-Fat; Diet, High-Protein; Diet, Western; | 2021 |
L-carnitine ameliorated fasting-induced fatigue, hunger, and metabolic abnormalities in patients with metabolic syndrome: a randomized controlled study.
Topics: Administration, Intravenous; Adult; Alanine Transaminase; Blood Glucose; Blood Pressure; Body Mass I | 2014 |
Weight loss favorably modifies anthropometrics and reverses the metabolic syndrome in premenopausal women.
Topics: Adult; Anthropometry; Body Composition; Carnitine; Diet, Reducing; Dietary Proteins; Dietary Supplem | 2005 |
27 other studies available for carnitine and Metabolic Syndrome
| Article | Year |
|---|---|
Targeted Metabolomics Revealed a Sex-Dependent Signature for Metabolic Syndrome in the Mexican Population.
Topics: Carnitine; Citrulline; Cohort Studies; Female; Glycine; Humans; Male; Metabolic Syndrome; Metabolomi | 2022 |
Dietary supplementation of L-carnitine ameliorates metabolic syndrome independent of trimethylamine
Topics: Animals; Carnitine; Diet, High-Fat; Dietary Supplements; Gastrointestinal Microbiome; Humans; Metabo | 2022 |
The association between acylcarnitine and amino acids profile and metabolic syndrome and its components in Iranian adults: Data from STEPs 2016.
Topics: Adult; Carnitine; Chromatography, Liquid; Citrulline; Cross-Sectional Studies; Diabetes Mellitus, Ty | 2023 |
Genetic and Lifestyle-Related Factors Influencing Serum Hyper-Propionylcarnitine Concentrations and Their Association with Metabolic Syndrome and Cardiovascular Disease Risk.
Topics: Aged; Amino Acids; Cardiovascular Diseases; Carnitine; Genome-Wide Association Study; Humans; Kinesi | 2023 |
Knockout of the non-essential gene SUGCT creates diet-linked, age-related microbiome disbalance with a diabetes-like metabolic syndrome phenotype.
Topics: Aging; Animals; Anti-Bacterial Agents; Bacteria; Carnitine; Coenzyme A-Transferases; Dietary Supplem | 2020 |
Targeted Metabolomics for Plasma Amino Acids and Carnitines in Patients with Metabolic Syndrome Using HPLC-MS/MS.
Topics: Amino Acids; Biomarkers; Carnitine; Case-Control Studies; Chromatography, High Pressure Liquid; Fema | 2020 |
Acyl-Carnitine plasma levels and their association with metabolic syndrome in individuals with schizophrenia.
Topics: Adult; Biomarkers; Carnitine; Case-Control Studies; Female; Humans; Male; Metabolic Syndrome; Plasma | 2020 |
Metabolites that activate the inflammasome in nascent metabolic syndrome.
Topics: Adult; Carnitine; Caspase 1; Diabetes Mellitus, Type 2; gamma-Aminobutyric Acid; Humans; Inflammasom | 2021 |
The Effects of Vitamin E, Silymarin and Carnitine on the Metabolic Abnormalities Associated with Nonalcoholic Liver Disease.
Topics: Blood Glucose; Carnitine; Glucose; Humans; Insulin; Insulin Resistance; Liver; Metabolic Syndrome; N | 2022 |
How to Screen and Prevent Metabolic Syndrome in Patients of PCOS Early: Implications From Metabolomics.
Topics: Adolescent; Adult; Biomarkers; Carnitine; Female; Glutamic Acid; Humans; Leucine; Metabolic Syndrome | 2021 |
Changes to trimethylamine-N-oxide and its precursors in nascent metabolic syndrome.
Topics: Adult; Aged; Biomarkers; Carnitine; Choline; Female; Humans; Inflammation; Male; Metabolic Syndrome; | 2018 |
Improvement of insulin resistance via increase of GLUT4 and PPARγ in metabolic syndrome-induced rats treated with omega-3 fatty acid or l-carnitine.
Topics: Adiposity; Animals; Carnitine; Diet, Carbohydrate Loading; Diet, High-Fat; Dietary Supplements; Fatt | 2018 |
Erythrocyte PUFAs, circulating acylcarnitines, and metabolic syndrome risk: a prospective study in Chinese.
Topics: Aged; Carnitine; China; Erythrocytes; Fatty Acids, Unsaturated; Female; Humans; Male; Metabolic Synd | 2019 |
Pharmacokinetic and pharmacological effects of β-hydroxyphosphocarnitine in animal models.
Topics: Administration, Oral; Animals; Area Under Curve; Carnitine; Cholesterol; Fatty Liver; Half-Life; Ins | 2014 |
The Carnitine Palmitoyl Transferase (CPT) System and Possible Relevance for Neuropsychiatric and Neurological Conditions.
Topics: Animals; Brain; Cardiovascular Diseases; Carnitine; Carnitine O-Palmitoyltransferase; Ceramides; Dia | 2015 |
Modulation of tissue fatty acids by L-carnitine attenuates metabolic syndrome in diet-induced obese rats.
Topics: Animals; Carnitine; Diet, High-Fat; Dietary Carbohydrates; Dietary Supplements; Humans; Lipid Metabo | 2015 |
Comparison of serum carnitine levels and clinical correlates between outpatients and acutely hospitalised individuals with bipolar disorder and schizophrenia: A cross-sectional study.
Topics: Adult; Bipolar Disorder; Carnitine; Cross-Sectional Studies; Female; Hospitalization; Humans; Inpati | 2016 |
Association between Metabolite Profiles, Metabolic Syndrome and Obesity Status.
Topics: Adult; Amino Acids; Body Mass Index; Cardiovascular Diseases; Carnitine; Cholesterol; Cholesterol, H | 2016 |
Serum Chemerin in Obese Children and Adolescents Before and After L-Carnitine Therapy: Relation to Nonalcoholic Fatty Liver Disease and Other Features of Metabolic Syndrome.
Topics: Adolescent; Antioxidants; Biomarkers; Carnitine; Case-Control Studies; Chemokines; Child; Child, Pre | 2016 |
Oral supplementation of propionyl-l-carnitine reduces body weight and hyperinsulinaemia in obese Zucker rats.
Topics: Animals; Carnitine; Dietary Supplements; Disease Models, Animal; Dose-Response Relationship, Drug; E | 2009 |
Effects of Zn(II) complex with vitamins C and U, and carnitine on metabolic syndrome model rats.
Topics: Adipocytes; Adipose Tissue; Animals; Ascorbic Acid; Body Weight; Carnitine; Cell Separation; Diet; D | 2011 |
Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation.
Topics: Adipose Tissue; Amino Acids; Analysis of Variance; Animals; Biomarkers; Blotting, Western; Carnitine | 2012 |
Pharmacological evaluation of a β-hydroxyphosphonate analogue of l-carnitine in obese Zucker fa/fa rats.
Topics: Animals; Carnitine; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Glucose; | 2013 |
Similarities in serum acylcarnitine patterns in type 1 and type 2 diabetes mellitus and in metabolic syndrome.
Topics: Adult; Aged; Body Mass Index; Carnitine; Case-Control Studies; Diabetes Mellitus, Type 1; Diabetes M | 2013 |
Beneficial impact of L-carnitine in liver: a study in a rat model of syndrome X.
Topics: Administration, Oral; Animals; Carnitine; Disease Models, Animal; Fructose; Injections, Intraperiton | 2008 |
Increase in nitric oxide and reductions in blood pressure, protein kinase C beta II and oxidative stress by L-carnitine: a study in the fructose-fed hypertensive rat.
Topics: Animals; Blood Pressure; Carnitine; Disease Models, Animal; Hypertension; Male; Metabolic Syndrome; | 2007 |
Renoprotective action of L-carnitine in fructose-induced metabolic syndrome.
Topics: Animals; Antioxidants; Blood Glucose; Carnitine; Fructose; Kidney Diseases; Metabolic Syndrome; Oxid | 2008 |